Literature DB >> 26206265

Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain.

Donghong He1, Hu Chen1, Hisako Muramatsu2, Amy W Lasek1.   

Abstract

Alcohol engages signaling pathways in the brain. Midkine (MDK) is a neurotrophic factor that is over-expressed in the prefrontal cortex of alcoholics. MDK and one of its receptors, anaplastic lymphoma kinase (ALK), also regulate behavioral responses to ethanol in mice. The goal of this study was to determine whether MDK and ALK expression and signaling are activated by ethanol. We found that ethanol treatment of neuroblastoma cells increased MDK and ALK expression. We also assessed activation of ALK by ethanol in cells and found that ALK and ALK-dependent extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) phosphorylation increased rapidly with ethanol exposure. Similarly, treatment of cells with recombinant MDK protein increased ALK, ERK and STAT3 phosphorylation, suggesting that ethanol may utilize MDK to activate ALK signaling. In support of this, transfection of cells with MDK siRNAs attenuated ALK signaling in response to ethanol. Ethanol also activates ERK signaling in the brain. We found that inhibition of ALK or knockout of MDK attenuated ethanol-induced ERK phosphorylation in mouse amygdala. These results demonstrate that ethanol engages MDK and ALK signaling, which has important consequences for alcohol-induced neurotoxicity and the regulation of behaviors related to alcohol abuse.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  ALK; ERK; STAT3; addiction; alcohol; midkine

Mesh:

Substances:

Year:  2015        PMID: 26206265      PMCID: PMC4618084          DOI: 10.1111/jnc.13252

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  65 in total

Review 1.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

2.  Inhibition of insulin-like growth factor-1 receptor and IRS-2 signaling by ethanol in SH-SY5Y neuroblastoma cells.

Authors:  A E Seiler; B N Ross; R Rubin
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

3.  Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons.

Authors:  K Owada; N Sanjo; T Kobayashi; H Mizusawa; H Muramatsu; T Muramatsu; M Michikawa
Journal:  J Neurochem       Date:  1999-11       Impact factor: 5.372

Review 4.  Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.

Authors:  G Herradón; C Pérez-García
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

5.  Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway.

Authors:  B Souttou; N B Carvalho; D Raulais; M Vigny
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

6.  Midkine inhibits apoptosis via extracellular signal regulated kinase (ERK) activation in PC12 cells.

Authors:  K Owada; N Sanjyo; T Kobayashi; T Kamata; H Mizusawa; H Muramatsu; T Muramatsu; M Michikawa
Journal:  J Med Dent Sci       Date:  1999-03

7.  Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.

Authors:  Gerald E Stoica; Angera Kuo; Ciaran Powers; Emma T Bowden; Elaine Buchert Sale; Anna T Riegel; Anton Wellstein
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

8.  Alteration of midkine expression in the ischemic brain of humans.

Authors:  Manabu Wada; Makiko Kamata; Yoshinori Aizu; Takashi Morita; Jianguo Hu; Kiyomitsu Oyanagi
Journal:  J Neurol Sci       Date:  2002-08-15       Impact factor: 3.181

9.  Alcohol-induced c-Fos expression in the Edinger-Westphal nucleus: pharmacological and signal transduction mechanisms.

Authors:  Ryan K Bachtell; Natalia O Tsivkovskaia; Andrey E Ryabinin
Journal:  J Pharmacol Exp Ther       Date:  2002-08       Impact factor: 4.030

10.  Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.

Authors:  Kamaraj Sattu; Falko Hochgräfe; Jianmin Wu; Ganesh Umapathy; Christina Schönherr; Kristina Ruuth; Damini Chand; Barbara Witek; James Fuchs; Pui-Kai Li; Fredrik Hugosson; Roger J Daly; Ruth H Palmer; Bengt Hallberg
Journal:  FEBS J       Date:  2013-08-22       Impact factor: 5.542

View more
  13 in total

1.  Anaplastic lymphoma kinase regulates binge-like drinking and dopamine receptor sensitivity in the ventral tegmental area.

Authors:  John W Dutton; Hu Chen; Chang You; Mark S Brodie; Amy W Lasek
Journal:  Addict Biol       Date:  2016-01-11       Impact factor: 4.280

2.  Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.

Authors:  Miryam Pastor; Rosalía Fernández-Calle; Bruno Di Geronimo; Marta Vicente-Rodríguez; José María Zapico; Esther Gramage; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Leonor Puchades-Carrasco; Antonio Pineda-Lucena; Beatriz de Pascual-Teresa; Gonzalo Herradón; Ana Ramos
Journal:  Eur J Med Chem       Date:  2017-11-28       Impact factor: 6.514

3.  Using In Vitro Electrophysiology to Screen Medications: Accumbal Plasticity as an Engram of Alcohol Dependence.

Authors:  R Renteria; Z M Jeanes; R A Mangieri; E Y Maier; D M Kircher; T R Buske; R A Morrisett
Journal:  Int Rev Neurobiol       Date:  2016-03-24       Impact factor: 3.230

4.  Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor.

Authors:  Donghong He; Amy W Lasek
Journal:  Mol Pharmacol       Date:  2019-11-16       Impact factor: 4.436

Review 5.  From top to bottom: midkine and pleiotrophin as emerging players in immune regulation.

Authors:  Noah Sorrelle; Adrian T A Dominguez; Rolf A Brekken
Journal:  J Leukoc Biol       Date:  2017-03-29       Impact factor: 4.962

6.  Midkine in the mouse ventral tegmental area limits ethanol intake and Ccl2 gene expression.

Authors:  H Chen; D He; A W Lasek
Journal:  Genes Brain Behav       Date:  2017-05-02       Impact factor: 3.449

7.  Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol.

Authors:  Rosalía Fernández-Calle; Marta Vicente-Rodríguez; Miryam Pastor; Esther Gramage; Bruno Di Geronimo; José María Zapico; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Beatriz de Pascual-Teresa; Ana Ramos; Gonzalo Herradón
Journal:  Neuropharmacology       Date:  2018-05-09       Impact factor: 5.250

8.  Dependence-induced ethanol drinking and GABA neurotransmission are altered in Alk deficient mice.

Authors:  Paul Schweitzer; Chelsea Cates-Gatto; Florence P Varodayan; Tali Nadav; Marisa Roberto; Amy W Lasek; Amanda J Roberts
Journal:  Neuropharmacology       Date:  2016-03-02       Impact factor: 5.250

9.  Binge-like ethanol drinking activates anaplastic lymphoma kinase signaling and increases the expression of STAT3 target genes in the mouse hippocampus and prefrontal cortex.

Authors:  Kana Hamada; Laura B Ferguson; R Dayne Mayfield; Harish R Krishnan; Mark Maienschein-Cline; Amy W Lasek
Journal:  Genes Brain Behav       Date:  2021-02-28       Impact factor: 3.708

Review 10.  Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder.

Authors:  Kana Hamada; Amy W Lasek
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.